|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
5,685 |
$56,958.84 |
2.77% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
212 |
$50,644.45 |
2.46% |
| DexCom, Inc. |
DXCM |
252131107 |
553 |
$48,271.37 |
2.35% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$46,934.98 |
2.28% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,122 |
$46,801.92 |
2.27% |
| Insulet Corporation |
PODD |
45784P101 |
148 |
$46,498.64 |
2.26% |
| Cochlear Limited |
COH.AU |
Q25953102 |
232 |
$45,871.38 |
2.23% |
| ResMed Inc. |
RMD |
761152107 |
177 |
$45,666.00 |
2.22% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,997 |
$45,786.82 |
2.22% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
850 |
$45,169.00 |
2.19% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
597 |
$44,219.79 |
2.15% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,873 |
$43,971.68 |
2.14% |
| Agilent Technologies, Inc. |
A |
00846U101 |
372 |
$43,899.72 |
2.13% |
| Align Technology, Inc. |
ALGN |
016255101 |
232 |
$43,924.56 |
2.13% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
37 |
$43,464.64 |
2.11% |
| Boston Scientific Corporation |
BSX |
101137107 |
401 |
$43,071.41 |
2.09% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
545 |
$42,624.45 |
2.07% |
| Hologic, Inc. |
HOLX |
436440101 |
651 |
$42,419.16 |
2.06% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
766 |
$42,462.79 |
2.06% |
| Stryker Corporation |
SYK |
863667101 |
107 |
$42,332.41 |
2.06% |
| BioMerieux |
BIM.FP |
F1149Y232 |
303 |
$41,902.39 |
2.04% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
624 |
$41,897.44 |
2.04% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
321 |
$41,892.43 |
2.04% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,881 |
$41,333.75 |
2.01% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
76 |
$41,299.16 |
2.01% |
| Masimo Corporation |
MASI |
574795100 |
246 |
$41,382.12 |
2.01% |
| Steris Plc |
STE |
G8473T100 |
171 |
$41,077.62 |
2.00% |
| Waters Corporation |
WAT |
941848103 |
118 |
$41,186.72 |
2.00% |
| Abbott Laboratories |
ABT |
002824100 |
299 |
$40,666.99 |
1.98% |
| Danaher Corporation |
DHR |
235851102 |
206 |
$40,693.24 |
1.98% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
183 |
$40,040.40 |
1.95% |
| Baxter International Inc. |
BAX |
071813109 |
1,322 |
$40,030.16 |
1.94% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,655 |
$39,789.54 |
1.93% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$39,313.67 |
1.91% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
132 |
$39,328.00 |
1.91% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
160 |
$38,611.20 |
1.88% |
| Revvity, Inc. |
RVTY |
714046109 |
400 |
$38,688.00 |
1.88% |
| Alcon Inc. |
ALC.SW |
H01301128 |
428 |
$37,867.05 |
1.84% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
406 |
$37,952.88 |
1.84% |
| Penumbra, Inc. |
PEN |
70975L107 |
138 |
$35,414.94 |
1.72% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
87 |
$35,275.02 |
1.71% |
| Olympus Corporation |
7733.JP |
J61240107 |
2,940 |
$35,012.35 |
1.70% |
| The Cooper Companies, Inc. |
COO |
216648501 |
493 |
$35,081.88 |
1.70% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
360 |
$34,193.88 |
1.66% |
| Teleflex Incorporated |
TFX |
879369106 |
288 |
$34,087.68 |
1.66% |
| Terumo Corporation |
4543.JP |
J83173104 |
1,860 |
$34,226.98 |
1.66% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
1,934 |
$33,762.25 |
1.64% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
364 |
$33,200.44 |
1.61% |
| Becton, Dickinson and Company |
BDX |
075887109 |
187 |
$32,210.75 |
1.56% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
524 |
$30,926.48 |
1.50% |
| US Dollar |
$USD |
|
8,717 |
$8,717.08 |
0.42% |
| New Zealand Dollar |
$NZD |
|
533 |
$324.99 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Japanese Yen |
$JPY |
|
3,671 |
$25.49 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|